Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Simari

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Circulation|September 24, 2019
When Will Clinical Trials Finally Reflect Diversity?Robert D Simari
Circulation Research|June 10, 2017
Forging the Fate of Cellular Therapies for Cardiovascular DiseaseRobert D Simari
Trends in Cardiovascular Medicine|November 16, 2004
Autologous cell-based therapies for vascular diseaseRajiv Gulati, Robert D Simari
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2011
Tissue factor-thrombin-PAR-1 pathway: a novel link between bone marrow and blood vesselSinny Delacroix, Robert D Simari
Journal of the American College of Cardiology|August 7, 2010
Peripheral blood CD31+ cells for the treatment of ischemic vascular diseaseRobert D Simari, Rajiv Gulati
Archives of Pathology & Laboratory Medicine|February 28, 2002
Clinical trials in vascular gene therapy: the missing piece of the puzzleRobert D Simari, Timothy O'Brien
Disease Models & Mechanisms|March 5, 2009
Defining the potential for cell therapy for vascular disease using animal modelsRajiv Gulati, Robert D Simari
Circulation Research|November 25, 2005
The translation of transcriptionSorin Pislaru, Robert D Simari
The Medical Clinics of North America|July 21, 2007
Cell therapy for acute myocardial infarctionRajiv Gulati, Robert D Simari
Circulation|September 15, 2005
Cell therapy for angiogenesis: embracing diversityRajiv Gulati, Robert D Simari
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Circulation|September 24, 2019
When Will Clinical Trials Finally Reflect Diversity?Robert D Simari
Circulation Research|June 10, 2017
Forging the Fate of Cellular Therapies for Cardiovascular DiseaseRobert D Simari
Trends in Cardiovascular Medicine|November 16, 2004
Autologous cell-based therapies for vascular diseaseRajiv Gulati, Robert D Simari
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2011
Tissue factor-thrombin-PAR-1 pathway: a novel link between bone marrow and blood vesselSinny Delacroix, Robert D Simari
Journal of the American College of Cardiology|August 7, 2010
Peripheral blood CD31+ cells for the treatment of ischemic vascular diseaseRobert D Simari, Rajiv Gulati
Archives of Pathology & Laboratory Medicine|February 28, 2002
Clinical trials in vascular gene therapy: the missing piece of the puzzleRobert D Simari, Timothy O'Brien
Disease Models & Mechanisms|March 5, 2009
Defining the potential for cell therapy for vascular disease using animal modelsRajiv Gulati, Robert D Simari
Circulation Research|November 25, 2005
The translation of transcriptionSorin Pislaru, Robert D Simari
The Medical Clinics of North America|July 21, 2007
Cell therapy for acute myocardial infarctionRajiv Gulati, Robert D Simari
Circulation|September 15, 2005
Cell therapy for angiogenesis: embracing diversityRajiv Gulati, Robert D Simari
Pageof 14